glp-1 shortage us The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Novo Nordisk's semaglutide shortage officially

Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

Individual Response

While side effects are often cited as a reason for GLP-1 non-adherence, the gap in persistence for the same molecule reflects deeper behavioral and systemic challenges

An extensive breakdown of exactly why the GLP-1 hype is making people with eating disorder/weight stigma histories feel like they can't trust themselves.

Some GLP1 users report mood changes and anxiety, while others feel better than ever

Our private label GLP-1 Booster formula is strategically developed to allow partners to enter this high-growth category quickly, professionally, and with a clinically positioned product that resonates with modern weight-management consumers